Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for United-Guardian, Inc. (UG : NSDQ)

• Company Description    UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents. Number of Employees: 25

• Price / Volume Information    Yesterday's Closing Price: $6.35 Daily Weekly Monthly 20 Day Moving Average: 6,926 shares Shares Outstanding: 4.59 (millions) Market Capitalization: $29.17 (millions) Beta: 0.96 52 Week High: $12.76 52 Week Low: $6.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.89% -15.81% 12 Week -19.21% -22.34% Year To Date -33.58% -39.94%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 230 MARCUS BOULEVARD - HAUPPAUGE,NY 11788 USA ph: 631-273-0900 fax: 631-273-0858 None http://www.u-g.com

• General Corporate Information    Officers Ken Globus - Chairman Donna Vigilante - President Andrea Young - Chief Financial Officer Lawrence F. Maietta - Director Arthur M. Dresner - Director Peer Information United-Guardian, Inc. (BJCT) United-Guardian, Inc. (CADMQ) United-Guardian, Inc. (APNO) United-Guardian, Inc. (UPDC) United-Guardian, Inc. (IMTIQ) United-Guardian, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 910571108 SIC: 2844 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/20/26 Share - Related Items Shares Outstanding: 4.59 Most Recent Split Date: (:1) Beta: 0.96 Market Capitalization: $29.17 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 7.87% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.50 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 1.25 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.26 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/20/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 14.77 PEG Ratio: - Price Ratios Price/Book: 2.55 Price/Cash Flow: 8.72 Price / Sales: 2.90 EPS Growth vs. Year Ago Period: -68.42% vs. Previous Quarter: -57.14% Sales Growth vs. Year Ago Period: -26.01% vs. Previous Quarter: -20.23% ROE 09/30/25 - 17.20 06/30/25 - 22.45 03/31/25 - 24.98 ROA 09/30/25 - 14.72 06/30/25 - 19.22 03/31/25 - 21.52 Current Ratio 09/30/25 - - 06/30/25 - 6.73 03/31/25 - 6.06 Quick Ratio 09/30/25 - - 06/30/25 - 5.90 03/31/25 - 5.28 Operating Margin 09/30/25 - 19.48 06/30/25 - 23.55 03/31/25 - 25.30 Net Margin 09/30/25 - 19.48 06/30/25 - 23.56 03/31/25 - 25.31 Pre-Tax Margin 09/30/25 - - 06/30/25 - 29.81 03/31/25 - 32.00 Book Value 09/30/25 - - 06/30/25 - 2.49 03/31/25 - 2.36 Inventory Turnover 09/30/25 - - 06/30/25 - 3.57 03/31/25 - 3.98 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©